FindTrial
Sign In

The clinical study of the role of the level of CSF CXCL13 and the detection of Treponema pallidum DNA in CSF by highly sensitive method in the treatment for syphilis

The clinical study of the role of the level of CSF CXCL13 and the detection of Treponema pallidum DNA in CSF by highly sensitive method in the treatment of syphilis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDD-16009591
Enrollment
Unknown
Registered
2016-10-25
Start date
2016-11-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

syphilis

Interventions

Gold Standard:
Index test:

Sponsors

Shanghai Skin Disease Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. patients with syphilis; 2. Signed a patient authorization form to use and disclose personal health information (or informed consent, where applicable).

Exclusion criteria

Exclusion criteria: 1. patients with syphilis during pregnancy and nursing; 2. Currently on treatment for syphilis; 3. unwillingly participates in the clinical trial; 4. patients with heart, renal or hepatic dysfunction.

Design outcomes

Primary

MeasureTime frame
sensitivity;specificity;—

Countries

China

Contacts

Public ContactPingyu Zhou

Shanghai Skin Disease Hospital

zhoupingyu@medmail.com.cn+86 18017336631

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026